Advertisement

Zimmer Biomet Holdings, Inc. ZBH

Set alert

Price alert · ZBH

All alert types
94.52 USD -2.95 -3.03%

At close · Oct 30

95.00 +0.48 +0.51%

After hours · Oct 30, 4:51 PM ET

Bid
94.51 × 200
Ask
94.63 × 300
94.38 Day range 97.32
79.58 52-week range 103.18
YTD
+5.12%
1 year
-5.06%
Open
95.84
Prev close
97.47
Mkt cap
18.03B
Vol
3.61M
Avg vol
2.07M
EPS
4.12
P/E
22.94
Div yield
0.98%
More statistics
Low
94.38
High
97.32
Forward P/E
10.44
Beta
0.48
Short ratio
3.64
Inst. own
111.33%
Dividend
0.96
Ex-div date
Sep 29, 2026
Earnings
Nov 4, 2026
50-d avg
94.93
200-d avg
91.61
1y target
106.90

2Y chart

Chart tools
Interval

Events in this range
  • Dec 30, 2024Dividend: 0.24
  • Mar 31, 2025Dividend: 0.24
  • Jun 26, 2025Dividend: 0.24
  • Aug 7, 2025Earnings: 2.07; estimate 1.98; surprise 4.55%
  • Sep 30, 2025Dividend: 0.24
  • Nov 5, 2025Earnings: 1.9; estimate 1.87; surprise 1.6%
  • Dec 30, 2025Dividend: 0.24
  • Feb 10, 2026Earnings: 2.42; estimate 2.38; surprise 1.68%
  • Mar 31, 2026Dividend: 0.24
  • Apr 28, 2026Earnings: 2.09; estimate 1.86; surprise 12.37%
  • Jun 25, 2026Dividend: 0.24
  • Aug 5, 2026Earnings: 2.07; estimate 2.01; surprise 2.99%
  • Aug 6, 2026Rating: Bernstein · Market Perform → Market Perform
  • Aug 6, 2026Rating: RBC Capital · Outperform → Outperform
  • Aug 7, 2026Rating: Truist Securities · Hold → Hold
  • Aug 10, 2026Rating: Canaccord Genuity · Hold → Hold
  • Sep 30, 2026Dividend: 0.24
  • Oct 7, 2026Rating: Barclays · — → Equal-Weight
  • Oct 22, 2026Rating: Argus Research · Buy → Buy
Signals (121)
NameDateAgo
SMA: BearishOct 30, 20261 day ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 12, 20262 weeks ago
MACD: Buy SignalOct 12, 20262 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishSep 29, 20261 month ago
SMA: BullishSep 28, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BearishSep 17, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalAug 25, 20262 months ago
MACD: Buy SignalJul 28, 20263 months ago
SMA: BullishJul 24, 20263 months ago
MACD: Sell SignalJul 21, 20263 months ago
SMA: BearishJul 17, 20263 months ago
SMA: BullishJul 16, 20263 months ago
SMA: BearishJul 14, 20263 months ago
SMA: BullishJul 13, 20263 months ago
MACD: Buy SignalJul 10, 20263 months ago
SMA: BullishJul 2, 20264 months ago
MACD: Sell SignalJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
SMA: BearishJun 29, 20264 months ago
SMA: BullishJun 26, 20264 months ago
SMA: BullishJun 12, 20264 months ago
SMA: BearishJun 11, 20264 months ago
SMA: BullishJun 9, 20264 months ago
MACD: Buy SignalMay 15, 20265 months ago
RSI: OversoldMay 11, 20265 months ago
RSI: OversoldApr 28, 20266 months ago
MACD: Sell SignalApr 24, 20266 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BullishApr 20, 20266 months ago
SMA: BearishApr 15, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BullishApr 8, 20266 months ago
MACD: Buy SignalApr 1, 20267 months ago
SMA: BearishMar 18, 20267 months ago
SMA: BullishMar 11, 20267 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BearishMar 5, 20268 months ago
MACD: Sell SignalMar 4, 20268 months ago
SMA: BullishFeb 13, 20268 months ago
RSI: OverboughtFeb 13, 20268 months ago
SMA: BearishFeb 12, 20268 months ago
SMA: BullishFeb 11, 20268 months ago
SMA: BullishFeb 10, 20268 months ago
MACD: Buy SignalFeb 4, 20268 months ago
MACD: Sell SignalJan 14, 20269 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishJan 8, 20269 months ago
SMA: BearishJan 7, 20269 months ago
SMA: BullishJan 6, 20269 months ago
MACD: Buy SignalDec 30, 202510 months ago
MACD: Sell SignalDec 16, 202510 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BullishNov 25, 202511 months ago
MACD: Buy SignalNov 21, 202511 months ago
SMA: BearishNov 5, 202512 months ago
SMA: BearishNov 5, 202512 months ago
MACD: Sell SignalNov 5, 202512 months ago
RSI: OversoldNov 5, 202512 months ago
SMA: BullishNov 4, 202512 months ago
SMA: BullishNov 4, 202512 months ago
MACD: Buy SignalNov 4, 202512 months ago
MACD: Sell SignalOct 31, 20251 year ago
SMA: BearishOct 29, 20251 year ago
SMA: BearishOct 28, 20251 year ago
SMA: BullishOct 17, 20251 year ago
SMA: BullishOct 17, 20251 year ago
MACD: Buy SignalOct 16, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishOct 3, 20251 year ago
SMA: BearishSep 24, 20251 year ago
SMA: BearishSep 23, 20251 year ago
SMA: BullishSep 22, 20251 year ago
SMA: BullishSep 17, 20251 year ago
SMA: BearishSep 16, 20251 year ago
SMA: BearishSep 15, 20251 year ago
MACD: Sell SignalSep 2, 20251 year ago
RSI: OverboughtAug 22, 20251 year ago
RSI: OverboughtAug 20, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
SMA: BullishAug 7, 20251 year ago
SMA: BearishJul 30, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 18, 20251 year ago
SMA: BullishJul 14, 20251 year ago
SMA: BearishJul 11, 20251 year ago
SMA: BullishJul 9, 20251 year ago
MACD: Buy SignalJun 4, 20251 year ago
MACD: Sell SignalJun 2, 20251 year ago
MACD: Buy SignalMay 29, 20251 year ago
MACD: Sell SignalMay 22, 20251 year ago
MACD: Buy SignalMay 13, 20251 year ago
MACD: Sell SignalMay 5, 20251 year ago
RSI: OversoldMay 5, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
RSI: OversoldApr 15, 20251 year ago
SMA: BearishApr 4, 20251 year ago
MACD: Sell SignalApr 4, 20251 year ago
SMA: BullishMar 13, 20251 year ago
SMA: BearishMar 12, 20251 year ago
SMA: BullishMar 7, 20251 year ago
SMA: BearishFeb 26, 20251 year ago
SMA: BullishFeb 25, 20251 year ago
MACD: Buy SignalFeb 21, 20251 year ago
RSI: OversoldFeb 10, 20251 year ago
SMA: BearishFeb 6, 20251 year ago
SMA: BullishFeb 5, 20251 year ago
SMA: BearishFeb 4, 20251 year ago
MACD: Sell SignalFeb 4, 20251 year ago
SMA: BullishJan 16, 20251 year ago
MACD: Buy SignalJan 15, 20251 year ago
RSI: OversoldJan 8, 20251 year ago

Key statistics

Market cap
18.04B
Enterprise value
25.74B
Trailing P/E
22.95
Forward P/E
10.44
PEG ratio
0.61
Price / sales
2.12
Price / book
1.43
EPS (TTM)
4.12
Beta
0.48
Dividend yield
0.98%
Payout ratio
23.30%
Profit margin
9.48%
Revenue (TTM)
8.51B
Revenue growth
4.80%
Free cash flow
1.07B
Total cash
464.50M
Total debt
7.60B
Return on equity
6.41%
Shares outstanding
190.74M
Short % of float
5.51%
50-day average
94.93
200-day average
91.61

Analyst view

Consensus: buy

Buy
Price target (mean) 106.90 +13.1% upside
Target (low)
93.00
Target (mean)
106.90
Target (high)
130.00
Ratings (0m) 27 8 buy · 19 hold · 0 sell
  • Strong buy2
  • Buy6
  • Hold19
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 1.88.

Earnings history

Financials — quick view

All financials
ZBH Revenue — quarterly 2.18B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH Net income — quarterly 198.30M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ZBH EPS — quarterly 1.03
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ZBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20261.88———
Aug 5, 2026Jun 30, 20262.012.07+0.06+2.99%
Apr 28, 2026Mar 31, 20261.862.09+0.23+12.37%
Feb 10, 2026Dec 31, 20252.382.42+0.04+1.68%
Nov 5, 2025Sep 30, 20251.871.90+0.03+1.60%
Aug 7, 2025Jun 30, 20251.982.07+0.09+4.55%

Upgrades / downgrades

ZBH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 22, 2026Argus ResearchreitBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Aug 10, 2026Canaccord GenuitymainHoldHold
Aug 7, 2026Truist SecuritiesmainHoldHold
Aug 6, 2026RBC CapitalmainOutperformOutperform
Aug 6, 2026BernsteinmainMarket PerformMarket Perform

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ZBH — it syncs with the Stock Master app.

Insider holders

ZBH insider holders
InsiderRelationLatest transactionDateShares held
BEZJAK MARKOfficerConversion of Exercise of derivative securityMar 5, 202513,134
ELLINGSON RACHEL H.OfficerConversion of Exercise of derivative securityFeb 19, 202511,906
NOOR JEHANZEBOfficerConversion of Exercise of derivative securityMar 31, 20265,151
PHIPPS CHAD FOfficerSaleSep 3, 202665,231
STELLATO PAUL AOfficerConversion of Exercise of derivative securityMar 5, 20265,582
TORNOS IVANChief Executive OfficerConversion of Exercise of derivative securityMar 5, 202683,191

Institution ownership

ZBH institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.12.65%24,124,7352.28BJun 29, 2026
Blackrock Inc.8.19%15,614,8471.48BJun 29, 2026
Harris Associates L.P.6.68%12,738,0251.20BJun 29, 2026
Vanguard Capital Management LLC6.62%12,634,9371.19BJun 29, 2026
Capital International Investors6.39%12,183,6141.15BJun 29, 2026
State Street Corporation4.65%8,877,171839.38MJun 29, 2026

Fund ownership

ZBH fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.15%15,549,9001.47BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%6,141,461580.71MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund3.08%5,867,350554.79MJul 30, 2026
HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Fund2.95%5,621,292531.52MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%5,010,793473.80MJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.42%4,610,277435.92MSep 29, 2026
Advertisement